Lipids, blood pressure and kidney update 2014

被引:77
作者
Banach, Maciej [1 ]
Aronow, Wilbert S. [2 ]
Serban, Corina [3 ]
Sahebkar, Amirhossein [4 ,5 ]
Rysz, Jacek [1 ]
Voroneanu, Luminita [6 ,7 ]
Covic, Adrian [6 ,7 ]
机构
[1] Med Univ Lodz, Dept Hypertens, Chair Nephrol & Hypertens, Zeromskiego 113, PL-90549 Lodz, Poland
[2] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[3] Victor Babes Univ Med & Pharm, Discipline Pathophysiol, Dept Funct Sci, Timisoara, Romania
[4] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran
[5] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp, Metab Res Ctr, Perth, WA 6009, Australia
[6] CI Parhon Univ Hosp, Nephrol Clin, Dialysis & Renal Transplant Ctr, Iasi, Romania
[7] Grigore T Popa Univ Med & Pharm, Iasi, Romania
关键词
Blood pressure; Cholesterol; Dyslipidemia; Hypertension; Lipids; Renal disease; Statin intolerance statin myopathy; EXPERT CONSENSUS DOCUMENT; PCSK9; MONOCLONAL-ANTIBODY; CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; CHRONIC RENAL-DISEASE; CHOLESTEROL HDL-C; CARDIOVASCULAR RISK; FAMILIAL HYPERCHOLESTEROLEMIA; HYPERTENSIVE PATIENTS; DYSFUNCTIONAL-HDL;
D O I
10.1016/j.phrs.2015.03.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper is an effort to review all the most important studies and guidelines in the topics of lipid, blood pressure and kidney published in 2014. Irrespective of advances, the options for improving simultaneous hypercholesterolemia and hypertension management (as well as its complication - chronic kidney disease) remain a problem. Recommending hypolidemic, hypotensive and kidney disease drugs to obtain therapy targets in cardiovascular, diabetic, elderly and kidney disease (=high risk) patients might strengthen risk factor control, improve compliance and the therapy efficacy, and in the consequence reduce the risk of cardiovascular events and mortality rate. That is why the authors have decided to summary and discuss the recent scientific achievements in the field of lipid, blood pressure and kidney. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:111 / 125
页数:15
相关论文
共 180 条
[21]   Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel [J].
Banach, Maciej ;
Rizzo, Manfredi ;
Toth, Peter P. ;
Farnier, Michel ;
Davidson, Michael H. ;
Al-Rasadi, Khalid ;
Aronow, Wilbert S. ;
Athyros, Vasilis ;
Djuric, Dragan M. ;
Ezhov, Marat V. ;
Greenfield, Robert S. ;
Hovingh, G. Kees ;
Kostner, Karam ;
Serban, Corina ;
Lighezan, Daniel ;
Fras, Zlatko ;
Moriarty, Patrick M. ;
Muntner, Paul ;
Goudev, Assen ;
Ceska, Richard ;
Nicholls, Stephen J. ;
Broncel, Marlena ;
Nikolic, Dragana ;
Pella, Daniel ;
Puri, Raman ;
Rysz, Jacek ;
Wong, Nathan D. ;
Bajnok, Laszlo ;
Jones, Steven R. ;
Ray, Kausik K. ;
Mikhailidis, Dimitri P. .
ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (01) :1-23
[22]   Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials [J].
Banach, Maciej ;
Serban, Corina ;
Sahebkar, Amirhossein ;
Ursoniu, Sorin ;
Rysz, Jacek ;
Muntner, Paul ;
Toth, Peter P. ;
Jones, Steven R. ;
Rizzo, Manfredi ;
Glasser, Stephen P. ;
Lip, Gregory Y. H. ;
Dragan, Simona ;
Mikhailidis, Dimitri P. .
MAYO CLINIC PROCEEDINGS, 2015, 90 (01) :24-34
[23]   Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication [J].
Banach, Maciej ;
Bromfield, Samantha ;
Howard, George ;
Howard, Virginia J. ;
Zanchetti, Alberto ;
Aronow, Wilbert S. ;
Ahmed, Ali ;
Safford, Monika M. ;
Muntner, Paul .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (01) :219-226
[24]   Lipid, blood pressure and kidney update 2013 [J].
Banach, Maciej ;
Serban, Corina ;
Aronow, Wilbert S. ;
Rysz, Jacek ;
Dragan, Simona ;
Lerma, Edgar V. ;
Apetrii, Mugurel ;
Covic, Adrian .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (05) :947-961
[25]   Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance [J].
Banach, Maciej ;
Malodobra-Mazur, Malgorzata ;
Gluba, Anna ;
Katsiki, Niki ;
Rysz, Jacek ;
Dobrzyn, Agnieszka .
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (27) :4904-4912
[26]   PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders? [J].
Banach, Maciej ;
Rizzo, Manfredi ;
Obradovic, Milan ;
Montalto, Giuseppe ;
Rysz, Jacek ;
Mikhailidis, Dimitri P. ;
Isenovic, Esma R. .
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (21) :3869-3877
[27]   Blood Pressure J-Curve: Current Concepts [J].
Banach, Maciej ;
Aronow, Wilbert S. .
CURRENT HYPERTENSION REPORTS, 2012, 14 (06) :556-566
[28]   What should be the optimal levels of blood pressure: does the J-curve phenomenon really exist? [J].
Banach, Maciej ;
Michalska, Marta ;
Kjeldsen, Sverre E. ;
Malyszko, Jolanta ;
Mikhailidis, Dimitri P. ;
Rysz, Jacek .
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (12) :1835-1844
[29]   2014 Eighth Joint National Committee Panel Recommendation for Blood Pressure Targets Revisited Results From the INVEST Study [J].
Bangalore, Sripal ;
Gong, Yan ;
Cooper-DeHoff, Rhonda M. ;
Pepine, Carl J. ;
Messerli, Franz H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (08) :784-793
[30]   Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality [J].
Barylski, Marcin ;
Toth, Peter P. ;
Nikolic, Dragana ;
Banach, Maciej ;
Rizzo, Manfredi ;
Montalto, Giuseppe .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 28 (03) :453-461